Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
The following drugs were used in the study: Complete Freund’s Adjuvant (CFA) (Sigma Chemical Company, St. Louis, MO, USA) and TAT-cUBP1-USP5 (Genemed synthesis Inc., San Francisco, CA).
Copyright and License information: The Author(s) ©2016
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
